Abortion Access Could Be Limited Further By Mifepristone Case

Was the FDA wrong to approve a drug that's used in nearly all medication abortions in the U.S. — and should the drug, mifepristone, be taken off the market? Those questions were argued in court Wednesday, in a case heard by federal Judge Matthew Kacsmaryk, a Trump appointee, in Amarillo, Texas. This episode: White House correspondent Tamara Keith, national correspondent Sarah McCammon, and political correspondent Susan Davis. The podcast is produced by Elena Moore and Casey Morell. It is edited by Eric McDaniel. Our executive producer is Muthoni Muturi. Research and fact-checking by Devin Speak. Unlock access to this and other bonus content by supporting The NPR Politics Podcast+. Sign up via Apple Podcasts or at plus.npr.org . Giveaway: npr.org/politicsplusgiveaway Connect: Email the show at nprpolitics@npr.org Join the NPR Politics Podcast Facebook Group . Subscribe to the NPR Politics Newsletter . See pcm.adswizz.com for information about our collection and use of personal data for sponsorship and to manage your podcast sponsorship preferences. NPR Privacy Policy